ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 56452 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 56452; 2) Community: the network communities that were significantly associated with the response to NSC 56452; 3) Molecule: the relationships between components within communities and NSC 56452; 4) MDR: the compounds that were significantly associated with the NSC 56452.

NSC Compound Enrichment Correlation
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0454469012959173 0.094047917
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.0454469012959173 0.43484403
NSC 356885 Leucinostatin A (9CI) 0.0454469012959173 0.27445981
NSC 37168 Acco Naphthol AS-BS 0.0454469012959173 0.28768985
NSC 374028 Camptothecin Derivative 0.0454469012959173 0.18973904
NSC 378734 From Cephalodiscus gilchristi 0.0454469012959173 0.28179569
NSC 38086 Null 0.0454469012959173 0.40481337
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0459335986102865 0.095974905
NSC 123979 Thevetin 0.0459335986102865 0.16014327
NSC 176503 Fastigilin B 0.0459335986102865 0.25310432
Total:124  Current:113    [First] [Prev] [Next] [Last]